“According to U.S. Food and Drug Administration (FDA), Pfizer can provide a Supplemental New Drug Application (sNDA) for ELIQUIS (apixaban) for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the reduction in the risk of recurrent DVT and PE.”

The article cited AMA's Global Thrombosis Drug Market Study explored substantial growth with CAGR of 9.31%. According the report, Rising research and developments expenditure is one of the primary growth factors for the market. Incidence Rate of Cardiovascular and Trauma Diseases. is also expected to contribute significantly to the Thrombosis Drug market. Overall, Deep Vein Thrombosis applications of Thrombosis Drug, and the growing awareness of them, is what makes this segment of the industry important to its overall growth.

AMA’s Analyst on the Global Thrombosis Drug market identified that the demand is rising in many different parts of the world as "Growing Ratio of Deep Vein Thrombosis Leads to Grow the Market. " Furthermore, some recent industry insights like "In April 2019, Tufts Medical Center and Eskenazi Health launched a mHealth wearable designed to improve blood flow and reduce the chance of DVT in post-operative patients. It also offers lightweight, portable mobile health sleeve that wraps around a limb such as the leg." is constantly making the industry dynamic.

The report provides an in-depth analysis and forecast about the industry covering the following key features:
o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies
o Analyses the Global Thrombosis Drug market by Type, Application, and regions
o Analyzes the top 10 players in terms of market reach, business strategy, and business focus
o Provides stakeholders’ insights and key drivers & trends of the market

Market Size Estimation
In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Thrombosis Drug market and other related sub-markets covered in the study.

o Key & emerging players in the Thrombosis Drug market have been observed through secondary research.
o The industry’s supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes.
o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation
The overall Thrombosis Drug market size is calculated using market estimation process, the Thrombosis Drug market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Thrombosis Drug market size has been validated using both top-down and bottom-up approaches.